2016 Q4 Form 10-K Financial Statement

#000117184317001588 Filed on March 17, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q4 2015 Q3
Revenue $26.42M $28.37M $25.73M
YoY Change -6.89% -6.57% 1.11%
Cost Of Revenue $14.31M $15.45M $14.01M
YoY Change -7.35% -6.39% -0.01%
Gross Profit $12.11M $12.92M $11.73M
YoY Change -6.34% -6.77% 2.48%
Gross Profit Margin 45.83% 45.56% 45.57%
Selling, General & Admin $10.26M $10.30M $10.03M
YoY Change -0.39% 7.63% 21.72%
% of Gross Profit 84.76% 79.7% 85.56%
Research & Development $1.160M $1.530M $1.426M
YoY Change -24.18% -1.92% 34.66%
% of Gross Profit 9.58% 11.84% 12.16%
Depreciation & Amortization $990.0K $1.270M $1.060M
YoY Change -22.05% 16.51% 13.98%
% of Gross Profit 8.18% 9.83% 9.04%
Operating Expenses $13.23M $12.81M $12.50M
YoY Change 3.26% 9.1% 24.8%
Operating Profit -$1.123M $113.0K -$775.0K
YoY Change -1093.81% -94.67% -154.39%
Interest Expense $170.0K -$160.0K $204.0K
YoY Change -206.25% -23.81% -14.64%
% of Operating Profit -141.59%
Other Income/Expense, Net $135.0K -$434.0K -$321.0K
YoY Change -131.11% -54.27% -31.56%
Pretax Income -$988.0K -$321.0K -$1.096M
YoY Change 207.79% -127.39% -214.64%
Income Tax $332.0K $16.82M -$249.0K
% Of Pretax Income
Net Earnings -$1.320M -$17.14M -$847.0K
YoY Change -92.3% 90110.53% -233.81%
Net Earnings / Revenue -5.0% -60.42% -3.29%
Basic Earnings Per Share -$0.04 -$0.51 -$0.02
Diluted Earnings Per Share -$0.04 -$0.51 -$0.02
COMMON SHARES
Basic Shares Outstanding 34.37M shares 33.94M shares 33.93M shares
Diluted Shares Outstanding 33.93M shares

Balance Sheet

Concept 2016 Q4 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.600M $6.700M $6.100M
YoY Change -16.42% -52.48% -77.15%
Cash & Equivalents $5.596M $6.744M $6.090M
Short-Term Investments
Other Short-Term Assets $4.175M $3.873M $5.070M
YoY Change 7.8% -18.33% 24.82%
Inventory $19.96M $22.34M $23.01M
Prepaid Expenses
Receivables $15.75M $17.55M $15.59M
Other Receivables $4.200M $3.900M $5.100M
Total Short-Term Assets $45.47M $50.55M $52.32M
YoY Change -10.04% -11.42% -19.5%
LONG-TERM ASSETS
Property, Plant & Equipment $4.296M $5.902M $5.934M
YoY Change -27.21% 13.72% 44.41%
Goodwill $38.03M $40.36M $40.86M
YoY Change -5.76% 1.34% 13.69%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.0K $152.0K $349.0K
YoY Change -15.79% -60.0% -2.79%
Total Long-Term Assets $62.29M $69.50M $81.23M
YoY Change -10.37% -11.86% 14.21%
TOTAL ASSETS
Total Short-Term Assets $45.47M $50.55M $52.32M
Total Long-Term Assets $62.29M $69.50M $81.23M
Total Assets $107.8M $120.1M $133.6M
YoY Change -10.23% -11.67% -1.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.196M $8.782M $6.322M
YoY Change -29.45% 39.53% 23.96%
Accrued Expenses $4.550M $4.021M $3.840M
YoY Change 13.16% -9.68% -7.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.400M $2.400M $5.000M
YoY Change 0.0% -52.0% 0.0%
Total Short-Term Liabilities $14.60M $19.32M $17.27M
YoY Change -24.44% 6.76% 10.51%
LONG-TERM LIABILITIES
Long-Term Debt $11.37M $16.37M $15.15M
YoY Change -30.51% -0.49% -16.76%
Other Long-Term Liabilities $3.200M $3.000M $4.600M
YoY Change 6.67% -34.78% -14.81%
Total Long-Term Liabilities $11.37M $16.37M $15.15M
YoY Change -30.51% -0.49% -16.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.60M $19.32M $17.27M
Total Long-Term Liabilities $11.37M $16.37M $15.15M
Total Liabilities $35.57M $42.45M $39.27M
YoY Change -16.21% 4.95% -0.21%
SHAREHOLDERS EQUITY
Retained Earnings -$116.0M -$111.7M -$94.58M
YoY Change 3.86% 20.54% 2.06%
Common Stock $215.6M $211.9M $211.1M
YoY Change 1.74% 2.33% 2.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 7.746M shares 7.746M shares 7.746M shares
Shareholders Equity $72.20M $77.60M $94.29M
YoY Change
Total Liabilities & Shareholders Equity $107.8M $120.1M $133.6M
YoY Change -10.23% -11.67% -1.89%

Cashflow Statement

Concept 2016 Q4 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$1.320M -$17.14M -$847.0K
YoY Change -92.3% 90110.53% -233.81%
Depreciation, Depletion And Amortization $990.0K $1.270M $1.060M
YoY Change -22.05% 16.51% 13.98%
Cash From Operating Activities $1.720M $1.770M -$80.00K
YoY Change -2.82% 40.48% -113.33%
INVESTING ACTIVITIES
Capital Expenditures -$530.0K -$680.0K -$660.0K
YoY Change -22.06% -13.92% 37.5%
Acquisitions
YoY Change
Other Investing Activities $1.420M $0.00 -$10.00K
YoY Change -100.0%
Cash From Investing Activities $890.0K -$680.0K -$670.0K
YoY Change -230.88% -94.5% 39.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.210M -1.160M -410.0K
YoY Change 4.31% 6.42% -130.15%
NET CHANGE
Cash From Operating Activities 1.720M 1.770M -80.00K
Cash From Investing Activities 890.0K -680.0K -670.0K
Cash From Financing Activities -1.210M -1.160M -410.0K
Net Change In Cash 1.400M -70.00K -1.160M
YoY Change -2100.0% -99.43% -178.38%
FREE CASH FLOW
Cash From Operating Activities $1.720M $1.770M -$80.00K
Capital Expenditures -$530.0K -$680.0K -$660.0K
Free Cash Flow $2.250M $2.450M $580.0K
YoY Change -8.16% 19.51% -46.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets
DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets
-758000 USD
CY2016 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Plan Assets
DefinedBenefitPlanForeignCurrencyExchangeRateChangesPlanAssets
-3095000 USD
CY2015Q4 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-2815000 USD
CY2015Q4 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-2280000 USD
CY2015Q4 hbio Deferred Income Taxes On Pension Liabilities
DeferredIncomeTaxesOnPensionLiabilities
535000 USD
CY2015Q4 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
2815000 USD
CY2015 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0357 pure
CY2014 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0415 pure
CY2015 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0443 pure
CY2016 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0 pure
CY2015 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0 pure
CY2016 hbio Service Cost For Defined Benefit Plan
ServiceCostForDefinedBenefitPlan
0 USD
CY2015 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
70000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2458000 USD
CY2016 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0262 pure
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2280000 USD
CY2014 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
0.0443 pure
CY2016 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
0.0468 pure
CY2014 us-gaap Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
0 pure
CY2015 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate Support Methodology And Source Data
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRateSupportMethodologyAndSourceData
The discount rate assumptions used for pension accounting reflect the prevailing rates available on high-quality, fixed-income debt instruments with terms that match the average expected duration of the Company’s defined benefit pension plan obligations. The Company uses the iBoxx AA 15yr+ index, which matches the average duration of its pension plan liability of approximately 15 years. With the current base of assets in the pension plans, a one percent increase/decrease in the discount rate assumption would decrease/increase annual pension expense by approximately $##D<pen-disc-rate-change>.
CY2015Q4 us-gaap Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
1 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
945000 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.1
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-413864 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.84
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5022186 shares
CY2016Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.94
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.8
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1072653 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-301520 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
5.29
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-34576 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
5.56
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.56
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5578 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M3D
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
2156000 USD
CY2016Q4 hbio Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.2 pure
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2016 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2413000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.85 pure
CY2016Q4 hbio Employee Stock Purchase Plan Shares Authorized
EmployeeStockPurchasePlanSharesAuthorized
750000 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
725239 shares
CY2016Q4 hbio Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold
LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold
6000000 USD
CY2016Q4 hbio Lender Approval To Fund Acquisition With Equity In Excess Of Threshold
LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold
10000000 USD
CY2009Q3 hbio Previous Approved Credit Facility
PreviousApprovedCreditFacility
20000000 USD
CY2013Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000 USD
CY2013Q1 hbio Ddtl Threshold For Dollar For Dollar Reduction In Revolving Line
DdtlThresholdForDollarForDollarReductionInRevolvingLine
10000000 USD
CY2009Q3 hbio Interest Rate In Excess Of Libor On Credit Facility
InterestRateInExcessOfLiborOnCreditFacility
0.03 pure
CY2016Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
8700000 USD
CY2013Q4 hbio Transferof Delayed Draw Down Term Loan Capacity To Revolver Capacity
TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity
5000000 USD
CY2016 hbio Derivative Interest Rate Swap Effective Percentage
DerivativeInterestRateSwapEffectivePercentage
1 pure
CY2015 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
-4000 USD
CY2014 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
-67000 USD
CY2014 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
56000 USD
CY2015 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
4000 USD
CY2015Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
310000 USD
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
328000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17547000 USD
CY2015Q4 us-gaap Assets
Assets
120050000 USD
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3873000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
22343000 USD
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
995000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20872000 USD
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
310000 USD
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41724772 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33979265 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
42000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
50549000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
152000 USD
CY2015Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
2364000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8782000 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
752000 USD
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
290000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4021000 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
868000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19323000 USD
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16369000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3775000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
2985000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
42452000 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
416000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
211457000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-111723000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11884000 USD
CY2015Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120050000 USD
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(b)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Use of Estimates</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:27pt;' >The preparation of financial</font><font style='font-family:Times New Roman;font-size:10pt;' > statements in conformity with accounting principles generally accepted in the United States requires the use of management estimates. Such estimates include the determination and establishment of certain accruals and provisions, including those for invent</font><font style='font-family:Times New Roman;font-size:10pt;' >ory excess and </font><font style='font-family:Times New Roman;font-size:10pt;' >obsolescence, </font><font style='font-family:Times New Roman;font-size:10pt;' >income tax and reserves for bad debts. In addition, certain estimates are required in order to determine the value of assets and liabilities associated with acquisitions, as well as the Company&#8217;s defined benefit pension obligations</font><font style='font-family:Times New Roman;font-size:10pt;' >. Estimates are also required to e</font><font style='font-family:Times New Roman;font-size:10pt;' >valuate the value and recoverability of existing long-lived and intangible assets, including goodwill. On an ongoing basis, the Company reviews its estimates based upon currently available information. Actual results could differ materially from those esti</font><font style='font-family:Times New Roman;font-size:10pt;' >mates.</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ></p></div>
CY2014 us-gaap Revenues
Revenues
108663000 USD
CY2014 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
59319000 USD
CY2014 us-gaap Gross Profit
GrossProfit
49344000 USD
CY2014 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18225000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16826000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4880000 USD
CY2014 us-gaap Restructuring Charges
RestructuringCharges
1027000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
42726000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
6618000 USD
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-150000 USD
CY2014 us-gaap Interest Expense
InterestExpense
990000 USD
CY2014 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
74000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1135000 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2201000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2062000 USD
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2015 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
59941000 USD
CY2015 us-gaap Gross Profit
GrossProfit
48723000 USD
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20577000 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19832000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6420000 USD
CY2016 us-gaap Revenues
Revenues
104521000 USD
CY2016 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56106000 USD
CY2016 us-gaap Gross Profit
GrossProfit
48415000 USD
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20486000 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20950000 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5392000 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
788000 USD
CY2014 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
810000 USD
CY2016 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
50436000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-1713000 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
51412000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-2997000 USD
CY2015 us-gaap Interest Expense
InterestExpense
854000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1259000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1895000 USD
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
737000 USD
CY2016 us-gaap Interest Expense
InterestExpense
642000 USD
CY2016 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
3000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-179000 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15431000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1229000 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2015 us-gaap Depreciation
Depreciation
1745000 USD
CY2014 us-gaap Depreciation
Depreciation
1253000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
2355000 USD
CY2016 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2015 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-25000 USD
CY2014 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
810000 USD
CY2016 hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-27000 USD
CY2015 hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-85000 USD
CY2014 hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-120000 USD
CY2016 hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
20000 USD
CY2015 hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
9000 USD
CY2014 hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
47000 USD
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
309000 USD
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-7000 USD
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-67000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2722000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2819000 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2578000 USD
CY2016 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
91000 USD
CY2015 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
86000 USD
CY2014 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
61000 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-279000 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15116000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1412000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-566000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
735000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1248000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1223000 USD
CY2016 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
658000 USD
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
370000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2577000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1069000 USD
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-195000 USD
CY2015 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-311000 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1511000 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-345000 USD
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-187000 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
120000 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
28000 USD
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
727000 USD
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1786000 USD
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-836000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5383000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
705000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4351000 USD
CY2016 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-1445000 USD
CY2015 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-2960000 USD
CY2014 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-2005000 USD
CY2016 hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-34000 USD
CY2015 hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-18000 USD
CY2014 hbio Additions To Catalog Costs
AdditionsToCatalogCosts
0 USD
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1141000 USD
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4545000 USD
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12653000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7517000 USD
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9050000 USD
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5500000 USD
CY2016 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
4000000 USD
CY2015 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
5800000 USD
CY2014 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2200000 USD
CY2016 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
32000 USD
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
182000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2042000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2066000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4868000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-540000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1234000 USD
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1601000 USD
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-38000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7390000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11637000 USD
CY2016 us-gaap Interest Paid
InterestPaid
620000 USD
CY2014 us-gaap Interest Paid
InterestPaid
997000 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
963000 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
843000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25771000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2160000 USD
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
228000 USD
CY2014 hbio Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
327000 USD
CY2014 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
233000 shares
CY2014 hbio Shares Withheld For Taxes
SharesWithheldForTaxes
62000 shares
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4606000 USD
CY2015 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4936000 USD
CY2014 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-5941000 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-29000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-85000 USD
CY2014 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-99000 USD
CY2016 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
10000 USD
CY2015 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
8000 USD
CY2014 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
31000 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-252000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-248000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-207000 USD
CY2016 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
430000 USD
CY2015 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-1029000 USD
CY2014 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-114000 USD
CY2016 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
178000 USD
CY2015 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1277000 USD
CY2014 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-321000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4774000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3651000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5589000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9081000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22690000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3234000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
58000 USD
CY2015 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
241000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
40357000 USD
CY2015Q4 us-gaap Secured Debt
SecuredDebt
18733000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2450000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
11400000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33236569 shares
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
12811000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
113000 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
13850000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1468000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1264000 USD
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1105000 USD
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1055000 USD
CY2016Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0 USD
CY2015Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
132000 USD
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
193000 USD
CY2015Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
147000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1784000 USD
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1423000 USD
CY2016Q4 hbio Total Accrued Expenses
TotalAccruedExpenses
4550000 USD
CY2015Q4 hbio Total Accrued Expenses
TotalAccruedExpenses
4021000 USD
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
790000 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
677000 USD
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
424000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
960000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
673000 USD
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
451000 USD
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
103000 USD
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-840000 USD
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-182000 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1046000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1227000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1503000 USD
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
165000 USD
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-12000 USD
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-364000 USD
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-93000 USD
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
82000 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
22000 USD
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
110000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-161000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
67000 USD
CY2015 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 USD
CY2014 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
0 USD
CY2015 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-169000 USD
CY2014 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-385000 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
16401000 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1346000 USD
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-9000 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-34000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3107000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-3331000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1846000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
29000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-277000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2571000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
45000 USD
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1447000 USD
CY2015Q4 hbio Deferred Tax Assets Operating Loss And Credits Carryforwards
DeferredTaxAssetsOperatingLossAndCreditsCarryforwards
14456000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
107000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
535000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
2987000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
588000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23402000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-18823000 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4579000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
655000 USD
CY2015Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
9563000 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-4984000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
170000 USD
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1336000 USD
CY2016Q4 hbio Deferred Tax Assets Operating Loss And Credits Carryforwards
DeferredTaxAssetsOperatingLossAndCreditsCarryforwards
12586000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions
631000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Contingencies
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies
3262000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
23000 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20089000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-17840000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2249000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
349000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
7509000 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
-5260000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
250000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
35000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
62000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6744000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2630000 USD
CY2015 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
237000 shares
CY2015 hbio Shares Withheld For Taxes
SharesWithheldForTaxes
652000 shares
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
208000 USD
CY2015 hbio Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
773000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
94485000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
77598000 USD
CY2013Q4 us-gaap Shares Issued
SharesIssued
39385000 shares
CY2016 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
CY2015 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
CY2014 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
CY2015 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
711000 USD
CY2014 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
893000 USD
CY2016 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
683000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
12945000 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
13166000 USD
CY2015 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
668000 USD
CY2014 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
649000 USD
CY2016 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-304000 USD
CY2015 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-306000 USD
CY2014 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-259000 USD
CY2016 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2015 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2014 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2016 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
253000 USD
CY2015 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
349000 USD
CY2014 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
503000 USD
CY2015 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-1360000 USD
CY2015 hbio Service Cost For Defined Benefit Plan
ServiceCostForDefinedBenefitPlan
0 USD
CY2015 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
-918000 USD
CY2015 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
752000 USD
CY2016 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
-982000 USD
CY2016 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
632000 USD
CY2016 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
4636000 USD
CY2016 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
3868000 USD
CY2016 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
694000 USD
CY2014Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
16724000 USD
CY2015Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
15767000 USD
CY2016Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
19214000 USD
CY2014Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
21170000 USD
CY2016Q4 us-gaap Defined Benefit Plan Funded Status Of Plan
DefinedBenefitPlanFundedStatusOfPlan
-2962000 USD
CY2016Q4 hbio Deferred Income Taxes On Pension Liabilities
DeferredIncomeTaxesOnPensionLiabilities
504000 USD
CY2016Q4 us-gaap Defined Benefit Pension Plan Current And Noncurrent Liabilities
DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities
2962000 USD
CY2016Q4 us-gaap Defined Benefit Plan Amounts Recognized In Balance Sheet
DefinedBenefitPlanAmountsRecognizedInBalanceSheet
-2458000 USD
CY2014 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-337000 USD
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
21767000 USD
CY2015Q4 us-gaap Noncurrent Assets
NoncurrentAssets
26774000 USD
CY2016Q4 hbio Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
72196000 USD
CY2015Q4 hbio Segment Reporting Information Net Assets1
SegmentReportingInformationNetAssets1
77598000 USD
CY2014 hbio Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
-19000 USD
CY2015 hbio Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
-18000 USD
CY2013Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
358000 USD
CY2015Q3 us-gaap Revenues
Revenues
25731000 USD
CY2015Q4 us-gaap Revenues
Revenues
28370000 USD
CY2015Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14005000 USD
CY2015Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15446000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
11726000 USD
CY2015Q4 us-gaap Gross Profit
GrossProfit
12924000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
12501000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-775000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-321000 USD
CY2015Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-434000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1096000 USD
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-321000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-249000 USD
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16819000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-847000 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-17140000 USD
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2015Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
2246000 USD
CY2016 hbio Minimun Percentage Of Term Loan And Delayed Draw Term Loan On Which Interest Rate Required To Be Fixed
MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed
0.5 pure
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32170683 shares
CY2016 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
-3654000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5902000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18904000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14608000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1600000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1614000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1489000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1284000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1087000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2919000 USD
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9993000 USD
CY2016Q4 us-gaap Revenues
Revenues
26415000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2400000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2200000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2100000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2100000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2000000 USD
CY2016Q4 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
39241000 USD
CY2016Q4 hbio Total Intangible Assets
TotalIntangibleAssets
84882000 USD
CY2015 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-81000 USD
CY2015 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
-24000 USD
CY2016Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
193000 USD
CY2016 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-97000 USD
CY2016 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
143000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14134000 USD
CY2016 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-5065000 USD
CY2016 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-291000 USD
CY2016Q4 us-gaap Secured Debt
SecuredDebt
13746000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21920000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16018000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
45641000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-28170000 USD
CY2015Q4 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
41580000 USD
CY2015Q4 hbio Total Intangible Assets
TotalIntangibleAssets
89159000 USD
CY2014 hbio Fair Value Impairment Of Pension Assets
FairValueImpairmentOfPensionAssets
0 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1095190 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4197 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4097 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0129 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0172 pure
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M16D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M0D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
3497000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2755000 USD
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34211521 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33592775 shares
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2014 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1065886 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34211521 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33592775 shares
CY2016 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
81228 shares
CY2015Q2 hbio Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan
IncreaseInNumberOfSharesAuthorizedForIssuanceUnderStockOptionAndIncentivePlan
2500000 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
17508929 shares
CY2015Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
80000 USD
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
100000 USD
CY2016 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >(s)</font></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0pt;' >Recently </font><font style='font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;' >Issued Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >&#8220;Revenue from Contracts with Customers,&#8221;</font><font style='font-family:Times New Roman;font-size:10pt;' > a new accounting standard that provides for a comprehensive model to </font><font style='font-family:Times New Roman;font-size:10pt;' >use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within accounting principles generally accepted in the United States. Under this standard, revenue will be recognized to de</font><font style='font-family:Times New Roman;font-size:10pt;' >pict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. The Company expects to adopt this standard as of January 1, 2018 using the </font><font style='font-family:Times New Roman;font-size:10pt;' >modified retrospective approach. The Company intends to complete a comprehensive assessment of its contracts in 2017 concerning any </font><font style='font-family:Times New Roman;font-size:10pt;' >unique customer contract terms or transactions that could have implications to the timing of revenue recognition under the n</font><font style='font-family:Times New Roman;font-size:10pt;' >ew guidance</font><font style='font-family:Times New Roman;font-size:10pt;' >. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company expects this undertaking will be complete in the second half of 2017.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >In July 2015, the FASB issued&#160;ASU&#160;2015-11,&#160;</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Simplifying Measurement of Inventory</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >.&#160;The update requires measurement of most inventory &#8220;at the lower of cost and net</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > realizable value&#8221;, and applies to all entities that recognize inventory within the scope of ASC 330, except for inventory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective applicatio</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >n and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2016.&#160;</font><font style='font-family:Times New Roman;font-size:10pt;' >The Company will adopt this standard effective January 1, 2017. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Adoption of this guidance is not expected to have a material impa</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ct on the Company&#39;s consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:22.5pt;' >In February 2016, the FASB issued ASU 2016-02, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Leases</font><font style='font-family:Times New Roman;font-size:10pt;' >, </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the asse</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ts and liabilities for the rights and obligations created by lease terms of more than 12&#160;months. The update is effective for fiscal years beginning after December&#160;15, 2018. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The Company is evaluating the requirements of this guidance and has not yet determi</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >ned the impact of the adoption on its consolidated financial position, results of operations and cash flows, however, </font><font style='font-family:Times New Roman;font-size:10pt;' >assets and liabilities will increase upon adoption for right-of-use assets and lease liabilities. The Company&#8217;s future commitments under l</font><font style='font-family:Times New Roman;font-size:10pt;' >ease obligations are summarized in Note 14.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:22.5pt;color:#000000;' >In June 2016, the FASB issued ASU 2016-13,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160;</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Financial Instruments &#8211; Credit Losses (Topic 326), Measurement of credit losses on Financial Instruments.</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >&#160;</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >The update amends the FASB&#8217;s guidance on the impairment of </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >financial instruments. The ASU adds to U.S. GAAP an impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its est</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >imate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. The ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company is eva</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >luating the impact of ASU 2016-13 on its consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:22.5pt;color:#000000;' >In August 2016, the FASB issued ASU 2016-15,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160;</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Classification of Certain Cash Receipts and Cash Payments (Topic 230)</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160;</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >which amends ASC 230,</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160;</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Statement of Cash Flows</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >&#160;</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >to add or clarify </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal year. The Company is evaluating</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' > the impact of ASU 2016-13 on its consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;color:#000000;' >In March 2016, the FASB issued ASU 2016-09, </font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;color:#000000;' >Compensation &#8211; Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >, which simplifies the accounting for sh</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >are-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. </font><font style='font-family:Times New Roman;font-size:10pt;' >The Company will adopt this standard effective January 1, 2017. </font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >Adoption of t</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >his guidance is not expected to have a material impact on the Company&#39;s consolidated financial statements; however, the impact in any given period will be dependent upon changes in the company&#39;s stock price, the volume of employee stock option exercises an</font><font style='font-family:Times New Roman;font-size:10pt;color:#000000;' >d the timing of service and performance-based restricted unit vestings.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;margin-left:24.5pt;' >Recently Adopted Accounting Pronouncements</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:inherit;font-size:10pt;margin-left:24.5pt;' >In April 2015, the FASB issued ASU 2015-03,&#160;</font><font style='font-family:inherit;font-size:10pt;font-style:italic;' >Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs</font><font style='font-family:inherit;font-size:10pt;' >. Under </font><font style='font-family:inherit;font-size:10pt;' >this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and </font><font style='font-family:inherit;font-size:10pt;' >are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance as of January 1, 2016. The consolidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a</font><font style='font-family:inherit;font-size:10pt;' > restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such cost</font><font style='font-family:inherit;font-size:10pt;' >s as a direct deduction from the debt liability on the consolidated balance sheet.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In September 2015, the FASB issued&#160;ASU&#160;2015-16</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >,&#160;Simplifying the Accounting for Measurement-Period Adjustments</font><font style='font-family:Times New Roman;font-size:10pt;' >.&#160;The update eliminates the requirement to retrospectively adju</font><font style='font-family:Times New Roman;font-size:10pt;' >st financial statements for measurement-period adjustments that occur in periods after a business combination. Under the update, measurement-period adjustments are to be calculated as if they were known at the acquisition date, but are recognized in the re</font><font style='font-family:Times New Roman;font-size:10pt;' >porting period in which they are determined. Additional disclosures are required about the impact on current-period earnings. ASU 2015-16 requires prospective application to adjustments of provisional amounts that occur after the effective date. The update</font><font style='font-family:Times New Roman;font-size:10pt;' > was effective for fiscal years beginning after December 15, 2015.&#160;&#160;The Company adopted ASU 2015-16 on January 1, 2016. The adoption of ASU 2015-16 did not have a material impact&#160;on its consolidated financial statements.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;margin-top:0pt;margin-bottom:0pt;line-height:12pt;' ><font style='font-family:Times New Roman;font-size:10pt;margin-left:24.5pt;' >In November 2015, the FASB issued </font><font style='font-family:Times New Roman;font-size:10pt;' >ASU&#160;2015-17,&#160;</font><font style='font-family:Times New Roman;font-size:10pt;font-style:italic;' >Balance Sheet Classification of Deferred Taxes</font><font style='font-family:Times New Roman;font-size:10pt;' >. The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to cl</font><font style='font-family:Times New Roman;font-size:10pt;' >assify deferred taxes between current and noncurrent. The update is effective for fiscal years beginning after December 15, 2016.&#160;&#160;Early adoption is permitted at the beginning of an interim or annual period. As of January 1, 2016, the Company early adopted</font><font style='font-family:Times New Roman;font-size:10pt;' > the new guidance on a prospective basis and has presented all deferred tax assets and deferred tax liabilities as noncurrent in the consolidated balance sheet at December 31, 2016. Prior periods presented in the consolidated financial statements were not</font><font style='font-family:Times New Roman;font-size:10pt;' > retrospectively adjusted.</font></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p><p style='text-align:left;line-height:12pt;' ></p></div>
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
95468000 USD
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q2 us-gaap Revenues
Revenues
28800000 USD
CY2015Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16205000 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
12595000 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
12496000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
99000 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-526000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-427000 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-776000 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
349000 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8233000 USD
CY2015 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-3992000 USD
CY2015 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-341000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
47579000 USD
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-26707000 USD
CY2014Q4 us-gaap Goodwill
Goodwill
39822000 USD
CY2015 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1618000 USD
CY2015 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1455000 USD
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1800000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2100000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1700000 USD
CY2015 us-gaap Revenues
Revenues
108664000 USD
CY2016 us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
0 USD
CY2016Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
500000 USD
CY2016Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
400000 USD
CY2016Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
600000 USD
CY2016Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
500000 USD
CY2016Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
500000 USD
CY2016Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
3600000 USD
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000 USD
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000 USD
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000 USD
CY2016 us-gaap Defined Benefit Plans Estimated Future Employer Contributions In Next Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInNextFiscalYear
700000 USD
CY2015 hbio Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
-4000 USD
CY2014 hbio Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
27000 USD
CY2016 hbio Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
166000 USD
CY2015 hbio Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
15598000 USD
CY2014 hbio Deferred Federal And State Income Tax Expense Benefit Continuing Operations
DeferredFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
1793000 USD
CY2016 hbio Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
269000 USD
CY2015 hbio Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
14758000 USD
CY2014 hbio Deferred Income Taxes Amount
DeferredIncomeTaxesAmount
1611000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
285000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
406000 USD
CY2016Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14018000 USD
CY2015 hbio Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
1200000 USD
CY2014 hbio Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
1100000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6263112 shares
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.42
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
313559 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6690845 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
306397 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
463973 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.42
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.3
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.32
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
254685 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-237188 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-10335 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
116400 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-233098 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-40878 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.12
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.36
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.18
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.67
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.08
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1115300 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-847860 shares
CY2015 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
58823 shares
CY2014 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
57848 shares
CY2016Q4 hbio Incentive Stock Options Granted To Date
IncentiveStockOptionsGrantedToDate
10218057 shares
CY2015Q4 hbio Incentive Stock Options Granted To Date
IncentiveStockOptionsGrantedToDate
10218057 shares
CY2016Q4 hbio Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
13131374 shares
CY2015Q4 hbio Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
13088374 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5521283 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2526641 shares
CY2016Q4 hbio In The Money Stock Options Exercisable At The Reporting Date
InTheMoneyStockOptionsExercisableAtTheReportingDate
914492 shares
CY2016Q4 hbio Common Stock Market Value Per Share On Reporting Date
CommonStockMarketValuePerShareOnReportingDate
3.05
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
800000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1800000 USD
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M25D
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3800000 USD
CY2016 hbio Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
0.0841 pure
CY2014 hbio Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
0.0705 pure
CY2016 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
1.21
CY2014 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.18
CY2014 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-102000 USD
CY2014 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
49000 USD
CY2016Q1 us-gaap Revenues
Revenues
26963000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-221000 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-222000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-443000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
193000 USD
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-636000 USD
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2016Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14310000 USD
CY2016Q4 us-gaap Gross Profit
GrossProfit
12105000 USD
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
13228000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1123000 USD
CY2016Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
135000 USD
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-988000 USD
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
332000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-1320000 USD
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2016Q2 us-gaap Revenues
Revenues
26136000 USD
CY2016Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14461000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
11675000 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
12515000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-840000 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
73000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-767000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-713000 USD
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2015Q4 hbio Undistributed Foreign Earnings
UndistributedForeignEarnings
48700000 USD
CY2014Q4 hbio Undistributed Foreign Earnings
UndistributedForeignEarnings
51900000 USD
CY2016Q4 hbio Cash In Foreign Subsidiaries
CashInForeignSubsidiaries
4500000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
16400000 USD
CY2016Q4 hbio Net Operating Loss Carryforwards Subject To Annual Limitation
NetOperatingLossCarryforwardsSubjectToAnnualLimitation
4700000 USD
CY2016Q4 hbio Net Operating Loss Carryforwards Annual Limitation
NetOperatingLossCarryforwardsAnnualLimitation
700000 USD
CY2015Q4 hbio Cash Held In Foreign Subsidiaries Used For Foreign Capital Improvements
CashHeldInForeignSubsidiariesUsedForForeignCapitalImprovements
300000 USD
CY2016Q4 hbio Tax Liability On Foreign Earnings Repatriated
TaxLiabilityOnForeignEarningsRepatriated
1200000 USD
CY2016 us-gaap Foreign Earnings Repatriated
ForeignEarningsRepatriated
3500000 USD
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2016 hbio Shares Withheld For Taxes Value
SharesWithheldForTaxesValue
185000 USD
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
196000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
171000 USD
CY2016 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
302000 shares
CY2016 hbio Shares Withheld For Taxes
SharesWithheldForTaxes
296000 shares
CY2014Q4 us-gaap Shares Issued
SharesIssued
40309000 shares
CY2015Q4 us-gaap Shares Issued
SharesIssued
41725000 shares
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
695000 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1772000 shares
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
375000 shares
CY2016 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-1891000 USD
CY2016 hbio Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
-128000 USD
CY2015 hbio Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
32000 USD
CY2014 hbio Net Change In Income Tax Expense Benefit Resulting From Permanent Differences
NetChangeInIncomeTaxExpenseBenefitResultingFromPermanentDifferences
-93000 USD
CY2016 hbio Net Impact Of Foreign Rate Changes
NetImpactOfForeignRateChanges
30000 USD
CY2015 hbio Net Impact Of Foreign Rate Changes
NetImpactOfForeignRateChanges
89000 USD
CY2014 hbio Net Impact Of Foreign Rate Changes
NetImpactOfForeignRateChanges
0 USD
CY2016 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-89000 USD
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
127000 USD
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
35000 USD
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000 USD
CY2016Q4 hbio Deferred Tax Assets Tax Credits On Repatriation
DeferredTaxAssetsTaxCreditsOnRepatriation
0 USD
CY2015Q4 hbio Deferred Tax Assets Tax Credits On Repatriation
DeferredTaxAssetsTaxCreditsOnRepatriation
1728000 USD
CY2016Q4 hbio Deferred Tax Liabilities Indefinite Lived Intangible Assets
DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets
4567000 USD
CY2015Q4 hbio Deferred Tax Liabilities Indefinite Lived Intangible Assets
DeferredTaxLiabilitiesIndefiniteLivedIntangibleAssets
4593000 USD
CY2016Q4 hbio Deferred Tax Liabilities Definite Lived Intangible Assets
DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets
2593000 USD
CY2015Q4 hbio Deferred Tax Liabilities Definite Lived Intangible Assets
DeferredTaxLiabilitiesDefiniteLivedIntangibleAssets
2587000 USD
CY2016Q4 hbio Deferred Tax Liabilities On Repatriation
DeferredTaxLiabilitiesOnRepatriation
0 USD
CY2015Q4 hbio Deferred Tax Liabilities On Repatriation
DeferredTaxLiabilitiesOnRepatriation
1728000 USD
CY2016 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
291000 USD
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-983000 USD
CY2015Q4 hbio Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets
AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets
900000 USD
CY2016 hbio Defined Benefit Plan Increase Decrease In Discount Rate Percentage
DefinedBenefitPlanIncreaseDecreaseInDiscountRatePercentage
0.001 pure
CY2016 hbio Defined Benefit Plan Increase Decrease In Asset Return Percentage
DefinedBenefitPlanIncreaseDecreaseInAssetReturnPercentage
0.001 pure
CY2016 hbio Defined Benefit Plan Increase Decrease In Discount Rate Value
DefinedBenefitPlanIncreaseDecreaseInDiscountRateValue
30000 USD
CY2016 hbio Defined Benefit Plan Increase Decrease In Asset Return Value
DefinedBenefitPlanIncreaseDecreaseInAssetReturnValue
163000 USD
CY2016 hbio Defined Benefit Plan Average Pension Plan Liability
DefinedBenefitPlanAveragePensionPlanLiability
P15Y
CY2016 hbio Defined Benefit Plan Average Remaining Work Lifetime
DefinedBenefitPlanAverageRemainingWorkLifetime
P15Y
CY2016Q4 us-gaap Shares Issued
SharesIssued
42187000 shares
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15746000 USD
CY2016Q4 us-gaap Assets
Assets
107765000 USD
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1209000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4175000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
19955000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1157000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17471000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
0 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
45472000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000 USD
CY2016Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
2372000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6196000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
500000 USD
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
223000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4550000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
760000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14601000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11374000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6417000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
3177000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
35569000 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
418000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
215134000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116030000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16658000 USD
CY2016Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
10668000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
107765000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
38032000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
72196000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
0 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4296000 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
39000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
93000 USD
CY2016Q4 us-gaap Defined Benefit Plan Weighted Average Asset Allocations
DefinedBenefitPlanWeightedAverageAssetAllocations
1 pure
CY2016Q3 us-gaap Revenues
Revenues
25007000 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1401000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
130000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9340000 USD
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
823000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
9792000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10957000 USD
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
888000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10498000 USD
CY2013Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
305000 USD
CY2014Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
252000 USD
CY2014Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
252000 USD
CY2015 us-gaap Defined Benefit Plan Benefits Paid
DefinedBenefitPlanBenefitsPaid
-1021000 USD
CY2015 us-gaap Defined Benefit Plan Contributions By Plan Participants
DefinedBenefitPlanContributionsByPlanParticipants
0 USD
CY2015Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
18582000 USD
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
611000 USD
CY2016 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
309000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
758000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1638000 USD
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2015Q1 us-gaap Revenues
Revenues
25763000 USD
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14285000 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
11478000 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
12628000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1150000 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-614000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1764000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
12503000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-813000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-67000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-880000 USD
CY2016 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
11000 USD
CY2016 hbio Valuation Allowances And Reserves Currency Translation
ValuationAllowancesAndReservesCurrencyTranslation
-19000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5596000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
611000 USD
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42186827 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34441320 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7745507 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
52000 USD
CY2016 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-88000 USD
CY2014 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2156000 USD
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3497000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-4307000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-19039000 USD
CY2015 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.15
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5351621 shares
CY2015 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.12
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
43000 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-593596 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4096818 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
3.89
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.92
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.31
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.15
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.04
CY2015Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.85
CY2015 hbio Annualized Estimated Forfeiture Rate
AnnualizedEstimatedForfeitureRate
0.0806 pure
CY2014Q4 hbio Non Qualified Stock Options Granted To Date
NonQualifiedStockOptionsGrantedToDate
12143374 shares
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
676000 USD
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2014 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2016 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
1190000 USD
CY2015 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2014 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3078000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3608000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4417000 USD
CY2015 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
372000 USD
CY2016 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
-484000 USD
CY2016 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
50000 USD
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
928000 USD
CY2015 us-gaap Interest Paid
InterestPaid
854000 USD
CY2015Q4 hbio Cash In Foreign Subsidiaries
CashInForeignSubsidiaries
5700000 USD
CY2014 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
CY2015 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
0 USD
CY2016 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1417000 USD
CY2014 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
29000 USD
CY2014 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
52000 USD
CY2016 hbio Current Federal And State Income Tax Expense Benefit Continuing Operations
CurrentFederalAndStateIncomeTaxExpenseBenefitContinuingOperations
170000 USD
CY2016 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
497000 USD
CY2015 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
0 USD
CY2014 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
0 USD
CY2016 hbio Income Tax Reconciliation Foreign Operations Foreign Withholding Taxes
IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes
74000 USD
CY2015 hbio Income Tax Reconciliation Foreign Operations Foreign Withholding Taxes
IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes
0 USD
CY2014 hbio Income Tax Reconciliation Foreign Operations Foreign Withholding Taxes
IncomeTaxReconciliationForeignOperationsForeignWithholdingTaxes
0 USD
CY2016 hbio Income Tax Reconciliation Foreign Tax Credits Deduction
IncomeTaxReconciliationForeignTaxCreditsDeduction
1772000 USD
CY2015 hbio Income Tax Reconciliation Foreign Tax Credits Deduction
IncomeTaxReconciliationForeignTaxCreditsDeduction
0 USD
CY2014 hbio Income Tax Reconciliation Foreign Tax Credits Deduction
IncomeTaxReconciliationForeignTaxCreditsDeduction
0 USD
CY2016 hbio Income Tax Reconciliation Loss On Subsidiary Stock Sale
IncomeTaxReconciliationLossOnSubsidiaryStockSale
501000 USD
CY2015 hbio Income Tax Reconciliation Loss On Subsidiary Stock Sale
IncomeTaxReconciliationLossOnSubsidiaryStockSale
0 USD
CY2014 hbio Income Tax Reconciliation Loss On Subsidiary Stock Sale
IncomeTaxReconciliationLossOnSubsidiaryStockSale
0 USD
CY2016Q4 hbio Undistributed Foreign Earnings
UndistributedForeignEarnings
48600000 USD
CY2016Q4 hbio Additional Paid In Capital Net Operating Loss Impact On Deferred Tax Assets
AdditionalPaidInCapitalNetOperatingLossImpactOnDeferredTaxAssets
0 USD
CY2016 hbio Income Tax Rate Reconciliation Deductions Stock Options
IncomeTaxRateReconciliationDeductionsStockOptions
1600000 USD
CY2015 hbio Income Tax Rate Reconciliation Deductions Stock Options
IncomeTaxRateReconciliationDeductionsStockOptions
1600000 USD
CY2016 hbio Business Acquisition Direct Acquisition Costs In Income Statement
BusinessAcquisitionDirectAcquisitionCostsInIncomeStatement
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
5000 USD
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
18000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2076000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1491000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
59000 USD
CY2016Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
200000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
59000 USD
CY2016Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
-104000 USD
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
-167000 USD
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
35000 USD
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001123494
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016 dei Entity Registrant Name
EntityRegistrantName
HARVARD BIOSCIENCE INC
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Trading Symbol
TradingSymbol
HBIO
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34582588 shares
CY2016Q2 dei Entity Public Float
EntityPublicFloat
89715296 USD
CY2016Q2 hbio Non Affiliate Share Holding
NonAffiliateShareHolding
31368985 shares

Files In Submission

Name View Source Status
0001171843-17-001588-index-headers.html Edgar Link pending
0001171843-17-001588-index.html Edgar Link pending
0001171843-17-001588.txt Edgar Link pending
0001171843-17-001588-xbrl.zip Edgar Link pending
exh_1015.htm Edgar Link pending
exh_1042.htm Edgar Link pending
exh_211.htm Edgar Link pending
exh_231.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10k_031617.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hbio-20161231.xml Edgar Link completed
hbio-20161231.xsd Edgar Link pending
hbio-20161231_cal.xml Edgar Link unprocessable
hbio-20161231_def.xml Edgar Link unprocessable
hbio-20161231_lab.xml Edgar Link unprocessable
hbio-20161231_pre.xml Edgar Link unprocessable
perf.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending